JIR
ZYME icon

James Investment Research’s Zymeworks ZYME Stock Holding History

James Investment Research’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Hold
10,925
– – 0.03% 315
2026
Q1 		$274K Hold
10,925
– – 0.03% 304
2025
Q4 		$288K Buy
10,925
+347
+3% +$7.57K 0.03% 304
2025
Q3 		$181K Hold
10,578
– – 0.02% 327
2025
Q2 		$133K Hold
10,578
– – 0.02% 312
2025
Q1 		$126K Hold
10,578
– – 0.02% 302
2024
Q4 		$155K Hold
10,578
– – 0.02% 304
2024
Q3 		$133K Hold
10,578
– – 0.02% 308
2024
Q2 		$90K Hold
10,578
– – 0.01% 307
2024
Q1 		$111K Buy
+10,578
New +$117K 0.01% 302

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

James Investment Research's ZYME Position: Q2 2026 in Review

James Investment Research held its Zymeworks (ZYME) position steady in Q2 2026 at 10,925 shares worth $286K. The position accounts for 0.03% of the portfolio, ranked #315.

James Investment Research first reported a position in ZYME in Q1 2024 and has held it in 10 quarters since. The position peaked at $288K in Q4 2025. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • James Investment Research held 10,925 shares of Zymeworks worth $286K as of Q2 2026.
  • James Investment Research left its Zymeworks share count unchanged in Q2 2026.
  • Zymeworks made up 0.03% of James Investment Research's portfolio in Q2 2026, its #315 holding.
  • James Investment Research first reported a position in Zymeworks in Q1 2024 and has held it in 10 quarters since.
  • James Investment Research's Zymeworks position peaked at $288K in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.